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More than 20 Mio tons of cheese are produced world-wide per year. By improving cheese yield and quality 
through process optimization, the amount of milk needed for manufacturing can be reduced significantly. 
Chymosin, an aspartic acid protease, is initiating milk coagulation in cheese manufacturing by cleaving off the 
glycomacropeptide (GMP) from the surface of casein micelles. Non-specific proteolysis of casein molecules by 
chymosin during this milk clotting process releases soluble peptides into the whey, resulting in protein losses 
from the cheese. The ratio between specific clotting activity (C) and non-specific proteolysis (P) of a coagulant 
can therefore be used as predictor for cheese yield. During ripening of the cheese, remaining coagulant 
continues proteolytic break-down of the caseins with significant impact on cheese properties. While the main 
proteolytic activity, the release of N-terminal peptides from alphaS1 casein (alphaS1-N), is associated with 
cheese softening and loss of firmness, cleavage of the C-terminal end of beta casein (beta-C) contributes to 
unwanted bitterness of the cheese [1]. The chymosin from Bos taurus (bovine chymosin) is traditionally used as 
milk coagulant in cheese manufacture. However, the homologous enzyme from Camelus dromedarius (camel 
chymosin) has been shown to be a superior alternative for various cheese types, since it reveals higher specific 
activity (C) and specificity (C/P) for the milk clotting reaction [2], as well as lower alphaS1 and beta casein 
proteolysis during ripening (Fig. 1). 
 
We have further improved the catalytic properties of 
camel chymosin by enzyme engineering, applying a 
combined rational, bioinformatics and directed 
evolution approach [3]. Mutations selected by 
structural and sequence comparison of bovine and 
camel chymosin [4] as well as from multiple sequence 
alignments of homologous enzymes were evaluated in 
multiple rounds of diversity generation and functional 
screening. Gene libraries were designed by DoE 
principles and the impact of the tested mutations on 
proteolytic activity and specificity were determined by 
sequence-function models (ProteinGPS technology 
provided by ATUM [5]). The resulting high information 
content of the libraries yielded sufficient improvement 
of four parameters after analysis of only about 500 
variants. This efficiency allowed us to screen the 
enzyme variants in near-product grade quality in 
application relevant assays, including an LC-MS/MS-
based mapping of casein degradation products in 
model cheeses. Compared to the wild type starting 
point, the best camel chymosin variant showed about 
two-fold increased specific milk-clotting activity, a 30-
fold higher C/P ratio, as well as 60% and 80% 
reduced alphaS1-N and beta-C casein proteolysis, respectively (Fig. 1).  
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Figure 1 – Properties of wild type chymosins and an 
improved variant 
